Figure 10. HBV DNA loss at the end of the drug therapies for chronic hepatitis B (significant risk differences from individual RCTs and pooled with random effects model).

Figure 10HBV DNA loss at the end of the drug therapies for chronic hepatitis B (significant risk differences from individual RCTs and pooled with random effects model)

From: Appendix E Tables and Figures

Cover of Management of Chronic Hepatitis B
Management of Chronic Hepatitis B.
Evidence Reports/Technology Assessments, No. 174.
Wilt TJ, Shamliyan T, Shaukat A, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.